Alkem Laboratories Limited (NSE:ALKEM)

Alkem Laboratories Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	150,813	147,123	129,645	126,676	115,993	106,342
Revenue Growth	13.36%	13.48%	2.34%	9.21%	9.07%	19.96%
Gross Profit Gross Profit Growth	97,732	94,343	80,391	76,034	65,785	63,536
Operating Income Operating Income Growth	26,159	26,014	21,518	19,676	13,196	17,432
Net Income Net Income Growth	21,575	23,018	21,655	17,958	9,842	16,456
Earnings Per Share EPS Growth	180.45	192.51	181.11	150.19	82.31	137.63
EPS Growth	-5.56%	6.30%	20.59%	82.47%	-40.20%	3.82%

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	102,077	99,749	91,436	86,620	81,600	75,266
United States (US) United States (US) Growth	30,081	29,624	24,818	27,709	25,134	23,291
Other International Other International Growth	18,979	17,750	13,392	12,346	9,259	7,785
Total Total Growth	151,137	147,123	129,645	126,676	115,993	106,342

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	40,615	40,615	37,779	38,023	11,432	13,130
Total Debt Total Debt Growth	20,472	20,472	13,809	14,184	13,967	26,682
Net Cash (Debt) Net Cash Growth	20,143	20,143	23,970	23,839	-2,535	-13,552
Net Cash Growth	-15.97%	-15.97%	0.55%	-	-	-
Net Cash Per Share Net Cash Per Share Growth	168.47	168.47	200.48	199.38	-21.20	-113.34

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-	19,630	19,128	19,481	16,825	11,110
Capital Expenditures CapEx Growth	-	-6,173	-6,756	-2,593	-2,329	-3,389
Free Cash Flow Free Cash Flow Growth	-	13,458	12,372	16,888	14,496	7,721
Free Cash Flow Growth	-	8.77%	-26.74%	16.50%	87.74%	-27.84%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	64.80%	64.13%	62.01%	60.02%	56.72%	59.75%
Operating Margin	17.34%	17.68%	16.60%	15.53%	11.38%	16.39%
Pretax Margin	19.03%	19.50%	19.49%	15.97%	11.25%	17.34%
Profit Margin	14.31%	15.65%	16.70%	14.18%	8.48%	15.47%
FCF Margin	-	9.15%	9.54%	13.33%	12.50%	7.26%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	53.000	53.000	45.000	40.000	25.000	34.000
Dividend Per Share Growth	17.78%	17.78%	12.50%	60.00%	-26.47%	13.33%
Dividend Yield	0.99%	1.00%	0.93%	0.83%	0.76%	0.98%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	29.75	27.53	26.95	32.91	41.26	26.31
Forward PE	26.26	27.02	24.55	28.26	26.11	23.64
P/FCF Ratio	47.69	47.08	47.18	34.99	28.01	56.07
PS Ratio	4.26	4.31	4.50	4.67	3.50	4.07

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 15, 2026

Data Sources Report a data error